Skip to main content

Pathological Roles Of Recoverin In Cancer-Associated Retinopathy

  • Chapter
Photoreceptors and Calcium

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 514))

Abstract

Cancer associated retinopathy (CAR) is an ocular manifestation of paraneoplastic syndrome clinically characterized by progressive visual impairment similar to retinitis pigmentosa. As a possible mechanism causing the retinal degeneration, the presence of serum autoantibodies against recoverin and other retinal antigens are involved. The molecular pathology in CAR by anti-recoverin antibody is considered to occur in the following steps: Firstly, recoverin aberrantly expressed in cancerous tissues is recognized by immunocytes by some unknown mechanisms and then a specific antibody toward recoverin is produced. Secondly, the anti-recoverin antibody reaches the retina via the peripheral circulation and is taken up into photoreceptor cells. Lastly, the antibody blocks recoverin function (inhibition of rhodopsin phosphorylation in a calcium dependent manner), and enhancement of rhodopsin phosphorylation induces retinal apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sawyer RA, Selhorse JB, Zimmerman LE. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 1976; 90:606–613.

    Google Scholar 

  2. Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration: Possible autoimmune disorder. Arch Ophthalmol 1983; 101:564–569.

    Article  PubMed  CAS  Google Scholar 

  3. Jacobson DM, Thirkill CE, Tipping SJ. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 1990; 28:162–167.

    Article  PubMed  CAS  Google Scholar 

  4. Polans AS, Buczylko J, Crabb J et al. A photoreceptor calcium-binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 1991; 112:981–989.

    Article  PubMed  CAS  Google Scholar 

  5. Ohguro H, Ogawa K, Nakagawa T. Both recoverin and hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1999; 40:82–89.

    PubMed  CAS  Google Scholar 

  6. Adamus, G, Aptsiauri N, Guy J et al. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol 1996; 78:120–129.

    Article  PubMed  CAS  Google Scholar 

  7. Komgruth SE, Kalinke T, Grunwald GB et al. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res 1986; 46:2588–2595.

    Google Scholar 

  8. Polans AS, Witkowska D, Haley TL et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 1995; 92:9176–9180.

    Article  PubMed  CAS  Google Scholar 

  9. Maeda A, Ohguro H, Maeda T et al. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res 2000; 60:1914–1920.

    PubMed  CAS  Google Scholar 

  10. Maeda T, Maeda A, Maruyama I et al. Mechanisms of photoreceptor cell death in Cancer-associated retinopathy. Invest Ophthalmol Vis Sci 2001; 42:705–712.

    PubMed  CAS  Google Scholar 

  11. Ohguro H, Ogawa K, MaedaTet al. Cancer-associated retinopathy induced by both antirecoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci 1999; 40:3160–3167.

    PubMed  CAS  Google Scholar 

  12. Adamus G, Machnicki M, Seigel GM. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1997; 38:283–291.

    PubMed  CAS  Google Scholar 

  13. Adamus G, Machnicki M, Elerding H et al. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 1998; 11:523–533.

    Article  PubMed  CAS  Google Scholar 

  14. Frasson M, Sahel JA, Fabre M et al. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nature Med 1999; 5:1183–1187.

    Article  PubMed  CAS  Google Scholar 

  15. Bush RA, Kononen L, Machida S et al. The effect of calcium channel blocker diltiazem on photoreceptor degeneration in the rhodopsin Pro23His rat. Invest Ophthalmol Vis Sci 2000; 41:2697–2701.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ohguro, H., Nakazawa, M. (2002). Pathological Roles Of Recoverin In Cancer-Associated Retinopathy. In: Baehr, W., Palczewski, K. (eds) Photoreceptors and Calcium. Advances in Experimental Medicine and Biology, vol 514. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0121-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0121-3_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4933-4

  • Online ISBN: 978-1-4615-0121-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics